LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Tianlong Contributes to China’s Power to Prevent and Control Global Epidemics

By LabMedica International staff writers
Posted on 02 Jan 2023
Print article
Image: Tianlong exports its products to more than 100 countries and regions worldwide (Photo courtesy of Tianlong)
Image: Tianlong exports its products to more than 100 countries and regions worldwide (Photo courtesy of Tianlong)

Since the year 2003, Tianlong Science and Technology (Shaanxi, China) has witnessed several health crises globally and has also contributed to China’s power to prevent and control major epidemics such as COVID-19, SARS, Avian influenza, Ebola, Zika, and African swine fever.

Tianlong is an innovative high-tech company specializing in molecular diagnostic products. Since being founded in 1997, Tianlong has devoted itself to providing integrated PCR lab solutions for professionals worldwide. The company has a wide range of products from devices to reagents, including nucleic acid extractors, real-time PCR systems, all-in-one molecular diagnosis systems, sample processing systems, liquid handling systems, and 300 kinds of compatible reagents.

With NMPA, CE, and FDA marks, Tianlong’s products are exported to more than 100 countries and regions worldwide, and have greatly helped in the prevention and control of epidemics such as COVID-19, SARS, Avian influenza, Ebola, Zika, and African swine fever. Tianlong continues to excel in R&D and bringing technology to life to make people's lives healthier and happier.

Related Links:
Tianlong Science and Technology

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
Real-time PCR System
GentierX3 Series

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: The AI predictive model identifies the most potent cancer killing immune cells for use in immunotherapies (Photo courtesy of Shutterstock)

AI Predicts Tumor-Killing Cells with High Accuracy

Cellular immunotherapy involves extracting immune cells from a patient's tumor, potentially enhancing their cancer-fighting capabilities through engineering, and then expanding and reintroducing them into the body.... Read more

Microbiology

view channel
Image: The T-SPOT.TB test is now paired with the Auto-Pure 2400 liquid handling platform for accurate TB testing (Photo courtesy of Shutterstock)

Integrated Solution Ushers New Era of Automated Tuberculosis Testing

Tuberculosis (TB) is responsible for 1.3 million deaths every year, positioning it as one of the top killers globally due to a single infectious agent. In 2022, around 10.6 million people were diagnosed... Read more